Massimo Triggiani

15.0k total citations · 1 hit paper
191 papers, 6.6k citations indexed

About

Massimo Triggiani is a scholar working on Immunology, Physiology and Molecular Biology. According to data from OpenAlex, Massimo Triggiani has authored 191 papers receiving a total of 6.6k indexed citations (citations by other indexed papers that have themselves been cited), including 94 papers in Immunology, 62 papers in Physiology and 49 papers in Molecular Biology. Recurrent topics in Massimo Triggiani's work include Mast cells and histamine (73 papers), Asthma and respiratory diseases (56 papers) and Food Allergy and Anaphylaxis Research (27 papers). Massimo Triggiani is often cited by papers focused on Mast cells and histamine (73 papers), Asthma and respiratory diseases (56 papers) and Food Allergy and Anaphylaxis Research (27 papers). Massimo Triggiani collaborates with scholars based in Italy, United States and Germany. Massimo Triggiani's co-authors include Gianni Marone, Francescopaolo Granata, Floyd H. Chilton, Angelica Petraroli, Amato de Paulis, Alfonso Oriente, Rosaria Ilaria Staiano, Alfred N. Fonteh, Stefania Loffredo and Arturo Genovese and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Journal of Clinical Investigation.

In The Last Decade

Massimo Triggiani

188 papers receiving 6.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group

2014 413 citations Massimo Triggiani et al. profile →

Peers

Countries citing papers authored by Massimo Triggiani

Since Specialization

Citations

This map shows the geographic impact of Massimo Triggiani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Massimo Triggiani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Massimo Triggiani more than expected).

Fields of papers citing papers by Massimo Triggiani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Massimo Triggiani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Massimo Triggiani. The network helps show where Massimo Triggiani may publish in the future.

Co-authorship network of co-authors of Massimo Triggiani

This figure shows the co-authorship network connecting the top 25 collaborators of Massimo Triggiani. A scholar is included among the top collaborators of Massimo Triggiani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Massimo Triggiani. Massimo Triggiani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Features of severe asthma response to anti-IL5/IL5r therapies: identikit of clinical remission 2024 ·Frontiers in Immunology ·Giovanna Elisiana Carpagnano, Andrea Portacci, Santi Nolasco, Aikaterini Detoraki, Alessandro Vatrella, Cecilia Calabrese, Corrado Pelaia, (unknown), Giulia Scioscia, Giuseppe Valenti, Maria D’Amato, Maria Filomena Caiaffa, Massimo Triggiani, Nicola Scichilone, Claudia Crimi	18
2	Benralizumab in Patients with Severe Eosinophilic Asthma: A Multicentre Real-Life Experience 2023 ·Journal of Clinical Medicine ·Giulia Scioscia, Pasquale Tondo, Santi Nolasco, Corrado Pelaia, Giovanna Elisiana Carpagnano, Maria Filomena Caiaffa, Giuseppe Valenti, Angelantonio Maglio, (unknown), Massimo Triggiani, Nunzio Crimi, Girolamo Pelaia, Alessandro Vatrella, Maria Pia Foschino Barbaro, Claudia Crimi	4
3	Real-world characteristics of “super-responders” to mepolizumab and benralizumab in severe eosinophilic asthma and eosinophilic granulomatosis with polyangiitis 2023 ·ERJ Open Research ·Andrea Portacci, Raffaele Campisi, Enrico Buonamico, Santi Nolasco, Corrado Pelaia, Nunzio Crimi, Alida Benfante, Massimo Triggiani, Giuseppe Spadaro, Maria Filomena Caiaffa, Giulia Scioscia, Aikaterini Detoraki, Giuseppe Valenti, (unknown), (unknown), Nicola Scichilone, (unknown), Claudia Crimi, Giovanna Elisiana Carpagnano	11
4	Pancarditis as the Clinical Presentation of Eosinophilic Granulomatosis with Polyangiitis: A Multimodality Approach to Diagnosis 2022 ·SHILAP Revista de lepidopterología ·Michele Lioncino, Emanuele Monda, Santo Dellegrottaglie, Annapaola Cirillo, Martina Caiazza, Adelaide Fusco, Francesca Esposito, Federica Verrillo, Giovanni Ciccarelli, Marta Rubino, Massimo Triggiani, Raffaele Scarpa, Alida L.P. Caforio, R Marcolongo, Stefania Rizzo, Cristina Basso, Gerardo Nigro, Maria Giovanna Russo, Paolo Golino, Giuseppe Limongelli	1
5	Drug-induced mast cell eradication: A novel approach to treat mast cell activation disorders? 2022 ·Journal of Allergy and Clinical Immunology ·Peter Valent, Cem Akin, Karin Hartmann, Andreas Reiter, Jason Gotlib, Karl Sotlar, Wolfgang R. Sperr, (unknown), (unknown), Massimo Triggiani, Hans‐Peter Horny, Michel Arock, Stephen J. Galli, Dean D. Metcalfe	17
6	Bone Marrow Failure Syndromes, Overlapping Diseases with a Common Cytokine Signature 2021 ·International Journal of Molecular Sciences ·Valentina Giudice, Chiara Cardamone, Massimo Triggiani, Carmine Selleri	20
7	Vascular endothelial growth factors and angiopoietins as new players in mastocytosis 2021 ·Clinical and Experimental Medicine ·Simone Marcella, Angelica Petraroli, Mariantonia Braile, Roberta Parente, Anne Lise Ferrara, Maria Rosaria Galdiero, Luca Modestino, Leonardo Cristinziano, Francesca Wanda Rossi, Gilda Varricchi, Massimo Triggiani, Amato de Paulis, Giuseppe Spadaro, Stefania Loffredo	14
8	Phenotypic and Functional Heterogeneity of Low-Density and High-Density Human Lung Macrophages 2021 ·Biomedicines ·Barbara Balestrieri, Francescopaolo Granata, Stefania Loffredo, Angelica Petraroli, Giulia Scalia, Paolo Morabito, Chiara Cardamone, Gilda Varricchi, Massimo Triggiani	17
9	Results from PIONEER: A randomized, double-blind, placebo-controlled, phase 2 study of avapritinib in patients with indolent systemic mastocytosis (ISM) 2020 ·University of Southern Denmark Research Portal (University of Southern Denmark) ·Marcus Maurer, (unknown), (unknown), Vito Sabato, Katrin Hartmann, Sigurd Broesby‐Olsen, Mariana Castells, (unknown), Mark Heaney, Tracy I. George, (unknown), Deepti Radia, Massimo Triggiani, (unknown), Daniel J. DeAngelo, Oleg Schmidt-Kittler, (unknown), (unknown), Brenton G. Mar, Cem Akin	1
10	COVID 19: a clue from innate immunity 2020 ·Immunologic Research ·(unknown), Maurizio Benucci, (unknown), (unknown), (unknown), (unknown), Gaetano Licata, Luca Quartuccio, Massimo Triggiani, (unknown)	120
11	Home Therapy with Plasma-Derived C1 Inhibitor: A Strategy to Improve Clinical Outcomes and Costs in Hereditary Angioedema 2015 ·International Archives of Allergy and Immunology ·Angelica Petraroli, (unknown), Nadia Di Paola, (unknown), Maria Bova, Rosanna Spanò, Gianni Marone, Massimo Triggiani	18
12	Activation of human inflammatory cells by secreted phospholipases A2 2006 ·Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids ·Massimo Triggiani, Francescopaolo Granata, Annunziata Frattini, Gianni Marone	94
13	Activation of Cytokine Production by Secreted Phospholipase A2 in Human Lung Macrophages Expressing the M-Type Receptor 2005 ·The Journal of Immunology ·Francescopaolo Granata, Angelica Petraroli, Éric Boilard, Sofiane Bezzine, James Bollinger, Luigi Del Vecchio, Michael H. Gelb, Gérard Lambeau, Gianni Marone, Massimo Triggiani	120
14	Mast cells and basophils: friends as well as foes in bronchial asthma? 2004 ·Trends in Immunology ·Giancarlo Marone, Massimo Triggiani, Amato de Paulis	90
15	Secretory Phospholipases A2 Activate Selective Functions in Human Eosinophils 2003 ·The Journal of Immunology ·Massimo Triggiani, Francescopaolo Granata, Barbara Balestrieri, Angelica Petraroli, Giulia Scalia, Luigi Del Vecchio, Gianni Marone	52
16	HIV-1 Envelope gp41 Peptides Promote Migration of Human FcεRI+ Cells and Inhibit IL-13 Synthesis Through Interaction with Formyl Peptide Receptors 2002 ·The Journal of Immunology ·Amato de Paulis, Giovanni Florio, Nella Prevete, Massimo Triggiani, Isabella Fiorentino, Arturo Genovese, Gianni Marone	29
17	Histamine Induces Exocytosis and IL-6 Production from Human Lung Macrophages Through Interaction with H1 Receptors 2001 ·The Journal of Immunology ·Massimo Triggiani, Marco Gentile, Agnese Secondo, Francescopaolo Granata, Alfonso Oriente, Maurizio Taglialatela, Lucio Annunziato, Gianni Marone	118
18	Secretory Phospholipases A2 Induce β-Glucuronidase Release and IL-6 Production from Human Lung Macrophages 2000 ·The Journal of Immunology ·Massimo Triggiani, Francescopaolo Granata, Alfonso Oriente, Valeria De Marino, Marco Gentile, Cecilia Calabrese, (unknown), Gianni Marone	68
19	Characterization of Platelet-activating Factor Acetylhydrolase in Human Bronchoalveolar Lavage 1997 ·American Journal of Respiratory and Critical Care Medicine ·Massimo Triggiani, Valeria De Marino, Matteo Sofia, Stanislao Faraone, Giuseppe Ambrosio, L Carratù, Gianni Marone	46
20	Migration of human inflammatory cells into the lung results in the remodeling of arachidonic acid into a triglyceride pool. 1995 ·The Journal of Experimental Medicine ·Massimo Triggiani, Alfonso Oriente, Michael C. Seeds, David Bass, Gianni Marone, Floyd H. Chilton	86

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact